In continuation towards the discovery of potential antiobesity lead(s) from natural products, we have screened n-hexane, dichloromethane (DCM), ethyl acetate (EtOAc) and methanol (MeOH) extracts of 33 Indian medicinal plants (200 extracts) for in vitro pancreatic lipase inhibitory activity. Of the screened extracts, the EtOAc extract of Cassia siamea roots showed 74.3±1.4% enzyme inhibition at 250 µg/mL concentration. Bioassay guided fractionation of the active extract afforded 6 known compounds viz. chrysophanol (1), physcion (2), emodin (3), cassiamin A (4), friedelin (5) and cycloart-25-en-3β,24-diol (6). These compounds were further evaluated for pancreatic lipase inhibitory activity. Cassiamin A (4), a bianthraquinone, was found to be most active with an IC 50 value of 41.8±1.2 µM and compounds 2 and 5 were found to be moderate enzyme inhibitors. Results indicate the antiobesity potential of C. siamea through pancreatic lipase inhibition.
Obesity is a chronic, stigmatized medical condition characterized as a Body Mass Index (BMI) exceeding 30 kg/m 2 . The imbalance caused by reduced expenditure and increased intake of energy leads to the over accumulation of fatty acids into adipose tissues. Morphologically obesity is also characterized by dysfunctioning of adipocytes [1] . Disturbance in the secretion of adipokines caused by obesity develops medical complications [2] . Once considered a problem only in high income countries, overweight and obesity are now dramatically on the rise in low and middle income countries, particularly in urban settings [3] . Obesity is an important risk factor for type 2 diabetes, hypertension, hyperlipidemia, atherosclerotic cardiovascular diseases, and osteoarthritis, as well as certain types of cancers [4] . The rate of obesity is increasing continuously and has tripled over the past three decades [5] .
Pancreatic lipase (pancreatic triacylgycerol lipase), a water soluble enzyme secreted from the pancreas, plays an important role in the digestion of dietary fats. It hydrolyses dietary triglycerides into monoglycerides and fatty acids to facilitate absorption of dietary fats. Fatty acids have high calorific values and play a vital role in the development of obesity by over accumulation into adipocytes. Reducing fat digestion through pancreatic lipase inhibition is an important approach for treatment of obesity [6] .
Natural products have made a continuous contribution in the discovery and development of lead molecules for several diseases. Lipstatin, an irreversible inhibitor of pancreatic lipase (IC 50 =0.14 µM), is a drug of natural origin [7] . A saturated derivative of lipstatin is orlistat, which is available on the market for the treatment of obesity.
Cassia siamea a plant (commonly known as yellow cassia or Thai copper pod) belonging to the family Caesalpiniaceae, is a native of Southeast Asia. Leaves of the plant are edible and are used traditionally in Thailand for preparing curry. It has been reported to possess antitumor promoting [8] , laxative [9] , antimalarial [10, 11] , antidiabetic, antilipidemic [12] , CNS inhibitory [13, 14] , vasorelaxant [15] , analgesic and anti-inflammatory activities [16] .
Thirty-three Indian medicinal plants were selected for screening on the basis of their reported antihyperlipidemic, anticholesterolemic and antidiabetic activities. All the extracts were screened for in vitro pancreatic lipase inhibitory activity; the results are summarized in Table 1 . Of all the extracts, the EtOAc extract of C. siamea (roots) showed the strongest pancreatic lipase inhibition, i.e. 74.3±1.4%, at the concentration of 250 µg/mL. In addition, DCM extracts of Lagerstroemia indica fruits showed 61.2 ±1.0% inhibition, and the EtOAc extract of Chukrasia tabularis leaves and bark 67.6±2.1% and 63.7±4.4% inhibition, respectively. Similarly, the EtOAc extract of Vigna radiata roots, L. indica fruits, Justicia gendarussa whole plant and Ferrula asaefoetida resin showed 64.6±0.2%, 70.1±1.2%, 61.1±2.6% and 72.5±3.5% enzyme inhibition, respectively. The MeOH extract of Ixora chinensis flowers also showed 66.0±2.1% enzyme inhibition.
On the basis of preliminary screening, the active EtOAc extract of C. siamea (roots) was selected for further phytochemical investigation. Fractionation of the EtOAc extract of C. siamea (roots) by vacuum liquid chromatography (VLC) resulted in 8 major fractions; these were examined in the pancreatic lipase inhibition assay. VLC fractions Fr IV, Fr V and Fr VI were found to be highly active with 94.9±2.0, 90.3±1.5 and 89.1±3.6% enzyme inhibition at 250 µg/mL ( Figure 1 ).
Based on the obtained results, Fr IV, having the highest pancreatic lipase inhibitory activity, was selected for isolation of compounds. The compounds isolated were identified by comparison of their physicochemical and spectroscopic data ( 1 H, 13 C NMR, 2D NMR and MS) with those in the literature. The compounds were identified as chrysophanol (1), physcion (2), emodin (3) [17] , cassiamin A (4) [18] , friedelin (5) [19] and cycloart-25-en-3β,24diol (6) [20] . All the compounds were assessed for pancreatic lipase inhibition. Orlistat was used as positive standard ((IC 50 0.012±0.002 µM). Cassiamin A (4) inhibited pancreatic lipase with an IC 50 value of 41.8±1.2 µM, which is moderately active compared with orlistat. Fractions IV, V and VI obtained from VLC had almost similar activity due to the distribution of the active compound, cassiamin A, among these fractions. Two others, physcion (2) and friedelin (5), showed weak pancreatic lipase inhibition with IC 50 values >250 µM, but chrysophanol (1), emodin (3) and cycloart-25-en-3β,24-diol (6) were inactive. However, our results for physcion (2) and emodin (3) are contrary to the reports for Chinese rhubarb [21] . Here we report for the first time the pancreatic lipase inhibitor activity of bianthraquinones. From this study we conclude that C. siamea has the potential to counteract obesity by pancreatic lipase inhibition. 
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Preparation of plant extracts:
All shade dried and coarsely powdered plant materials (40 g) were defatted with n-hexane and subjected to sequential extraction with DCM, EtOAc and MeOH by ASE. All the extracts were dried under vacuum on a rotary evaporator and stored under refrigeration until used for analysis.
Bioassay guided fractionation of C. siamea root extract:
The roots of C. siamea were shade dried and coarsely powdered using a cutter mill. The powdered roots (700 g), after defatting with n-hexane, were extracted with EtOAc (5 L) for 36 h using a Soxhlet apparatus. The extract was concentrated to dryness under vacuum on a rotary evaporator to give a dry residue (50 g), which was then further fractionated by vacuum liquid chromatography (VLC) (12.5 cm i.d. × 7 cm) on silica gel (230-400#) using a DCM: acetone (100:0 to 0:100, v/v) gradient. Fractions (20) were collected by increasing the polarity by 5% of acetone, with an eluting volume of 1L in each gradient. Eight major fractions (Fr I to Fr VIII) were obtained by pooling all the 20 fractions based on similar TLC profiles. Fraction IV (12.8 g) was subjected to CC (4 cm i.d. × 30 cm) using silica gel (60-120#) and eluted with a chloroform: MeOH gradient (100:0 to 0:100, v/v). All the fractions obtained were pooled into 6 sub fractions (Fr IVa to Fr IVf) on the basis of their TLC profile. CC (2.5 cm i.d. × 15 cm) of sub fraction Fr IVa (2.5 g) using silica gel (100-200#) with gradient elution with n-hexane: EtOAc (100:0 to 0:100, v/v) afforded 3 compounds, 1 (9 mg), 2 (7.3 mg) and 3 (13 mg). These three isolated compounds gave positive reactions in Borntrager′s test. Compound 4 (20 mg) was isolated by preparative TLC from Fr IVb (1.8 g) using silica gel G and n-hexane: EtOAc (3:2). Compounds 5 (10 mg) and 6 (10 mg) were isolated from subfraction Fr IVc (2.2 g) and Fr IVd (2.6 g), respectively using silica gel (100-200#) CC (2.5 cm i.d. × 15 cm) and a n-hexane: EtOAc gradient (100:0 to 0:100, v/v).
Pancreatic lipase inhibition assay:
The optimized pancreatic lipase inhibitory assay protocol, previously published from our laboratory, was followed [22] . Activity was measured using PNPP as an enzyme substrate and Orlistat as a positive standard. All the studies were undertaken in triplicate; mean values and standard errors of the mean were calculated. IC 50 values were calculated for active compounds.
